RTU Gemcad-200 Injection is an anti-cancer drug used in the treatment of various types of cancers. RTU Gemcad-200 Injection is used either independently or in conjunction with other chemotherapy medications to treat breast cancer, pancreatic cancer, non-small cell lung cancer, bladder cancer, and ovarian cancer. RTU Gemcad-200 Injection works by interfering with DNA synthesis. It blocks the production of new DNA, by locking itself into the DNA strands and inhibiting any further proliferation or growth of the cell. Hence, RTU Gemcad-200 Injection has widespread application in the field of oncology (cancer-related medicine) and chemotherapy.

FAQs

How does RTU Gemcad-200 Injection work?

RTU Gemcad-200 Injection works blocking DNA synthesis and causing cell death, thereby preventing the cells from proliferating beyond normal.

Does RTU Gemcad-200 Injection affect fertility?

Men taking RTU Gemcad-200 Injection are advised not to father a child during the treatment with RTU Gemcad-200 Injection and for 6months after the treatment. Consult your doctor before starting RTU Gemcad-200 Injection if you are planning to father a child. Your doctor may advise you regarding sperm storage.

I suffer from Chronic Kidney Disease (CKD). Can I take RTU Gemcad-200 Injection ?

If you suffer from CKD, please consult with your doctor before using RTU Gemcad-200 Injection and discuss any concerns with them. RTU Gemcad-200 Injection is to be used with caution in those suffering from kidney and liver problems.

Does RTU Gemcad-200 Injection increase the risk of infections?

RTU Gemcad-200 Injection might cause low white blood cell count leading to increased risk of infections. Consult your doctor if you have a fever, sweating, and any signs of infections.

Does RTU Gemcad-200 Injection cause bleeding or bruising?

RTU Gemcad-200 Injection may cause bleeding and bruising due to less platelet count. Consult a doctor if you notice unexpected bruising, pinkish or reddish urine, bleeding from gums, mouth, or nose.